Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review (original) (raw)
Antifungal drug dosing adjustment in critical patients with invasive fungal infections
Athina Pyrpasopoulou
Journal of Emergency and Critical Care Medicine
View PDFchevron_right
Choosing the Right Antifungal Agent in ICU Patients
nadim CASSIR
Advances in Therapy
View PDFchevron_right
Choice of initial antifungal therapy in critically Ill patients
sudha madhavan
International Journal of Health Sciences (IJHS), 2022
View PDFchevron_right
Timely selection of adequate antifungal therapy for candidemia in the critically ill: Donʼt let the yeast rise!*
Alberto Corona
Critical Care Medicine, 2008
View PDFchevron_right
Systemic antifungal therapy in critically ill patients without invasive fungal infection*
Hervé Dupont
Critical Care Medicine, 2012
View PDFchevron_right
Antifungal Dose Adjustment in Renal and Hepatic Dysfunction: Pharmacokinetic and Pharmacodynamic Considerations
David Burgess
Current Fungal Infection Reports, 2010
View PDFchevron_right
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy
Pankaj Jorwal
Revista iberoamericana de micología, 2006
View PDFchevron_right
Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?
M. Van Driel
International Journal of Infectious Diseases, 2019
View PDFchevron_right
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data
Philippe Montravers
Intensive Care Medicine, 2015
View PDFchevron_right
Incidence of candidaemia and antifungal sensitivity in critically ill patients
Vincenzo Vullo, Maria Mascellino
View PDFchevron_right
Susceptibility profiles and clinical efficacy of antifungals against candida bloodstream isolates from critically ill patients: Focus on intravenous itraconazole
Chrisostomos Katsenos
International Journal of Antimicrobial Agents, 2019
View PDFchevron_right
Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders
David Kong
Internal Medicine Journal, 2008
View PDFchevron_right
Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
Dominique Sanglard
Intensive Care Medicine, 2014
View PDFchevron_right
Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside
George Drusano
Clinical Microbiology and Infection, 2009
View PDFchevron_right
Pharmacokinetics of Anidulafungin in Critically Ill Intensive Care Unit Patients with Suspected or Proven Invasive Fungal Infections
Eleonora Swart
Antimicrobial Agents and Chemotherapy, 2017
View PDFchevron_right
Are prophylactic antifungals in highly colonized patients safe and effective?
Cristóbal León
Intensive Care Medicine, 2015
View PDFchevron_right
Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration
J. Belda
International journal of antimicrobial agents, 2017
View PDFchevron_right
A bedside scoring system (???Candida score???) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization
Pedro Saavedra
Critical Care Medicine, 2006
View PDFchevron_right
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients
J. Kosterink
Antimicrobial Agents and Chemotherapy, 2021
View PDFchevron_right
Management of candidiasis Management of Candida species infections in critically ill patients
Jorge Garbino
The Lancet Infectious Diseases, 2003
View PDFchevron_right
Empirical treatment of candidemia in intensive care units: Fluconazole or broad-spectrum antifungal agents?
Teresa Peláez
Medical Mycology, 2009
View PDFchevron_right
Antifungals patterns in critical patients with candidiasis in the intensive care units at Sanglah General Hospital 2019
Ady Widayana
Neurologico Spinale Medico Chirurgico, 2019
View PDFchevron_right
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials
massimo attanasio
Journal of Antimicrobial Chemotherapy, 2006
View PDFchevron_right
Invasive Candida Infections and the Harm From Antibacterial Drugs in Critically Ill Patients
Morten Bestle
Critical Care Medicine, 2015
View PDFchevron_right
How to treat fungal infections in ICU patients
Dimitrios Matthaiou
BMC Infectious Diseases, 2015
View PDFchevron_right
Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study
Jesús Gomez
Critical care medicine, 2017
View PDFchevron_right
Newer Systemic Antifungal Agents: Pharmacokinetics, Safety and Efficacy
Andreas Groll
Drugs, 2004
View PDFchevron_right
Invasive Fungal Infections in Critically Ill Patients
Armin Ahmed
2016
View PDFchevron_right
Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical Patients
Marie Diener-West
Annals of Surgery, 2001
View PDFchevron_right
Hospital use of systemic antifungal drugs
Frank Dörje
BMC clinical pharmacology, 2005
View PDFchevron_right
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study
Maria Sole Vallecoccia
Journal of Antimicrobial Chemotherapy, 2016
View PDFchevron_right
Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review
Johannes Reitsma
Critical Care, 2007
View PDFchevron_right